HEALTH CARE EQUIPMENT & SUPPLIES INDUSTRY

quantrx biomedical corp (QTXB:OTC US)

Last $0.03 USD

Change Today 0.00 / 0.00%

Volume 0.0

QTXB On Other Exchanges

Symbol

Exchange

QTXB:US

OTC US

As of 8:10 PM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements Ratios Pensions & Options SEC Filings

Financial Statements for quantrx biomedical corp (QTXB)

Year over year, QuantRx Biomedical Corporation has seen revenues shrink from $19.1K USD to $15.2K USD, though the company was able to grow net income from a loss of $783.6K USD to a smaller loss of $718.0K USD. A reduction in the percentage of sales devoted to selling, general and administrative costs from 3,844.32% to 3,110.70% was a key component in the bottom line growth in the face of falling revenues.

Income Statement Balance Sheet Cash Flow

Currency in Millions of US Dollars	As of:	Dec 31 2009	Dec 31 2010 Restated	Dec 31 2011	Dec 31 2012	4 Year Trend
Revenues		2.6	0.1	0.0	0.0
TOTAL REVENUES		2.6	0.1	0.0	0.0
Cost of Goods Sold		0.0	0.0	0.0	0.0
GROSS PROFIT		2.5	0.1	0.0	0.0
Selling General & Admin Expenses, Total		2.5	1.7	0.7	0.5
R&D Expenses		2.3	0.3	0.0	0.0
Depreciation & Amortization, Total		0.1	0.1	0.0	0.0
OTHER OPERATING EXPENSES, TOTAL		4.9	2.1	0.8	0.5
OPERATING INCOME		-2.4	-2.0	-0.8	-0.5
Interest Expense		-0.8	0.0	0.0	-0.1
Interest and Investment Income		0.0	0.0	0.0	0.0
Other Non-Operating Expenses, Total		0.0	0.0	--	-0.2
Other Non-Operating Income (Expenses)		0.0	0.0	--	-0.2
Gain (Loss) on Sale of Investments		-1.0	2.3	--	--
Gain (Loss) on Sale of Assets		1.0	0.0	--	0.0
Other Unusual Items, Total		--	0.6	0.3	0.1
EBT, INCLUDING UNUSUAL ITEMS		-3.2	0.9	-0.6	-0.7
Earnings from Continuing Operations		-3.2	0.9	-0.6	-0.7
EARNINGS FROM DISCOUNTINUED OPERATIONS		--	-0.1	-0.2	--
NET INCOME		-3.2	0.8	-0.8	-0.7
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		-3.2	0.4	-0.8	-0.7
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		-3.2	0.5	-0.6	-0.7